Objectives: The aim of this study was to evaluate the osteogenic potential of recombinant human bone morphogenetic protein-2 (rhBMP-2) and low-level laser irradiation (LLLI), isolated or combined in critical bone defects (5 mm) in parietal bone using ovariectomized female rats as an experimental animal model. Materials and Methods: Forty-nine female Wistar rats, bilaterally ovariectomized (OVX), were divided into seven treatment groups of seven animals each: (I) laser in a single application, (II) 7 μg of pure rhBMP-2, (III) laser and 7 μg of pure rhBMP-2, (IV) 7 μg of rhBMP-2/monoolein gel, (V) laser and 7 μg of rhBMP-2/monoolein gel, (VI) laser and pure monoolein gel, and (VII) critical bone defect controls. The low-level laser source used was a gallium aluminum arsenide semiconductor diode laser device (λ = 780 nm, D = 120 J/cm2). Results: Groups II and III presented higher levels of newly formed bone than all other groups with levels of 40.57% and 40.39%, respectively (p < 0.05). The levels of newly formed bone of groups I, IV, V, and VI were similar with levels of 29.67%, 25.75%, 27.75%, and 30.64%, respectively (p > 0.05). The area of new bone formation in group VII was 20.96%, which is significantly lower than groups I, II, III, and VI. Conclusions: It was concluded that pure rhBMP-2 and a single dose of laser application stimulated new bone formation, but the new bone formation area was significantly increased when only rhBMP-2 was used. Additionally, the laser application in combination with other treatments did not influence the bone formation area.
Get full access to this article
View all access options for this article.
References
1.
Consensus Development Conference. 1993. Diagnosis, prophylaxis and treatment of osteoporosis. Am. J. Med., 94:646–650.
2.
IssaJ.P., DefinoH.L., NettoJ.C.et al.2010. Evaluation of rhBMP-2 and natural latex as potential osteogenic proteins in critical size defects by histomorphometric methods. Anat. Rec. (Hoboken)., 293:794–801.
3.
SommernanM., HewittA.T., VarnerH.H., SchiffmannE., TermineJ., ReddiA.H.1983. Identification of bone matrix-derived chemotatic factor. Calcif. Tissue. Int., 35:481–485.
4.
BowersG.M., ReddiA.H.1992. Regeneration of the periodontium in advanced periodontal disease. J. Am. Dent. Assoc., 122:45–48.
5.
GerhartT.N., KirkeheadC.A., KrizM.J.et al.1991. Healing of large mid-femoral segmental defects in sheep using recombinant bone morphogenic protein (BMP-2). Trans. Orthop. Res. Soc., 16:172.
6.
ToriumiD.M., KotlerH.S., LuxenbergD.P., HoltropM.E., WangE.A.1991. Mandibular reconstruction with a recombinant bone-inducing factor. Functional, histologic, and biomechanical evaluation. Arch. Otolaryngol. Head Neck Surg., 117:1101–1112.
7.
DörtbudakO., HaasR., Mallath–PokornyG.2000. Biostimulation of bone marrow cells with a diode soft laser. Clin. Oral Implants. Res., 11:540–545.
8.
RennoA.C., de MouraF.M., dos SantosN.S., TiricoR.P., BossiniP.S., ParizottoN.A. 2006. Effects of 830-nm laser light on preventing bone loss after ovariectomy. Photomed. Laser Surg., 24:642–645.
9.
Pires–OliveiraD.A.A., OliveiraR.F., AmadeiS.U., Pacheco–SoaresC., RochaR.F.2010. Laser 904 nm action on bone repair in rats with osteoporosis. Osteoporos. Int., 21:2109–2114.
10.
KaluD.N.1991. The ovariectomized rat model of postmenopausal bone loss. Bone Miner., 15:175–191.
11.
MarcondesF.K., BianchiF.J., TannoA.P.2002. Determination of the estrous cycle phases of rats: Some helpful considerations. Braz. J. Biol., 62:609–614.
12.
WeibelE.R., KistlerG.S., ScherleW.F.1966. Practical stereological methods for morphometric cytology. J. Cell Biol., 30:23–38.
PengZ., TuukkanenJ., ZhangH., JämsäT., VäänänenH.K.1994. The mechanical strength of bone in different rat models of experimental osteoporosis. Bone., 15:523–532.
15.
IssaJ.P., do NascimentoC., BentleyM.V., Del BelE.A., IyomasaM.M., SebaldW., AlbuquerqueR.F.2008. Bone repair in rat mandible by rhBMP-2 associated with two carriers. Micron, 39:373–379.
16.
IssaJ.P., SpadaroA.C., BentleyM.V.et al.2008. Monoolein and chitosan gels as potential carriers of the rhBMP-2, using decortication surgical technique in Wistar rats as experimental model. Micron, 39:952–959.
17.
SchnettlerR., KnossP.D., HeissC.et al.2009. Enhancement of bone formation in hydroxyapatite implants by rhBMP-2 coating. J. Biomed. Mater. Res. B Appl. Biomater., 90:75–81.
18.
WangR., ZouY., YuanZ.et al.2009. Autografts and xenografts of skin fibroblasts delivering BMP-2 effectively promote orthotopic and ectopic osteogenesis. Anat. Rec. (Hoboken)., 292:777–786.
19.
GiannoudisP.V., DinopoulosH.T.2010. BMPs: Options, indications, and effectiveness. J. Orthop. Trauma. 24:Suppl, 1:S9–16.
20.
PengC.2003. The TGF-beta superfamily and its roles in the human ovary and placenta. J. Obstet. Gynaecol. Can., 25:834–844.
21.
DeckersM.M., van BezooijenR.L., van der HorstG.et al.2002. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology., 143:1545–1553.
22.
PengH., UsasA., OlshanskiA.et al.2005. VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J. Bone Miner. Res., 20:2017–2027.
23.
ThiesR.S., BauduyM., AshtonB.A., KurtzbergL., WozneyJ.M., RosenV.1992. Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology, 130:1318–1324.
24.
HanadaK., DennisJ.E., CaplanA.I.1997. Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. J. Bone Miner. Res., 12:1606–1614.
25.
HanadaK., SolchagaL.A., CaplanA.I.et al.2001. BMP-2 induction and TGF-beta 1 modulation of rat periosteal cell chondrogenesis. J. Cell Biochem., 81:284–294.
26.
YuY.Y., LieuS., LuC., ColnotC.2010. Bone morphogenetic protein 2 stimulates endochondral ossification by regulating periosteal cell fate during bone repair. Bone, 47:65–73.
27.
DinizJ.S., NicolauR.A., OcarinoN.M., MagalhãesF.C., PereiraR.D.O., SerakidesR.2009. Effect of low-power gallium-aluminum-arsenium laser therapy (830 nm) in combination with bisphosphonate treatment on osteopenic bone structure: An experimental animal study. Lasers Med. Sci., 24:347–352.
28.
WangE.A., RosenV., D'AlessandroJ.S.et al.1990. Recombinant human bone morphogenetic protein induces bone formation. Proc. Natl. Acad. Sci. USA., 87:2220–2224.
29.
AbdalaP.M., IyomasaM.M., SatoS.et al.2010. Osteoinductivity potential of rhBMP-2 associated with two carriers in different dosages. Anat. Sci. Int., 85:181–188.
30.
HerrenD.B., NagyL., CampbellD.A.2008. Osteosynthesis in the hand: current concepts: FESSH instructional course. Basel: Karger.
31.
BaxterG.D.1997. Therapeutic Lasers: Theory and Practice. New York: Churchill Livingstone.
32.
SteinA., BenayahuD., MaltzL., OronU.2005. Low-level laser irradiation promotes proliferation and differentiation of human osteoblasts in vitro. Photomed. Laser Surg., 23:161–166.
